Review maps broader global footprint for Potomac horse fever agent

A newly published systematic review is putting fresh attention on the global footprint of Neorickettsia risticii, the bacterium classically associated with Potomac horse fever. The paper, published March 18, 2026, in Veterinary Research Communications, synthesizes a literature base that has long been fragmented across countries and host species. Its release comes alongside a broader 2026 review in Veterinary Microbiology that describes equine neorickettsiosis as a geographically and ecologically complex disease involving trematodes, snails, aquatic insects, and multiple vertebrate hosts. (deepdyve.com)

That broader framing matters because Potomac horse fever has historically been discussed as a mostly North American seasonal disease, especially in horses near waterways. But the disease ecology has been widening for years. AAEP’s current disease guidance says Potomac horse fever is caused by both N. risticii and N. findlayensis, and that horses in endemic areas are susceptible, with cases typically appearing in summer and fall depending on weather conditions. Quebec’s animal health guidance also describes reported cases in Canada, the U.S., South America, Europe, and India, underscoring how the literature and surveillance picture have expanded beyond the disease’s original Mid-Atlantic identity. (aaep.org)

The science behind that expansion is tied to the organism’s unusual life cycle. Neorickettsia species are endosymbionts of digenean trematodes, which cycle through snails and aquatic insects before incidental exposure in horses. Earlier experimental work helped establish that horses could be infected through naturally infected aquatic insects and helminth vectors, a finding that still anchors today’s understanding of environmental exposure risk. The newer global-perspective review emphasizes that the natural habitat of these bacteria, and therefore disease risk, depends on local parasite ecology as much as on horse movement or traditional maps of endemicity. (pubmed.ncbi.nlm.nih.gov)

Recent literature also shows why this is more than an academic mapping exercise. A Brazilian study confirmed molecular detection of N. risticii in horses from Rio de Janeiro, adding to evidence from South America. Cornell’s Animal Health Diagnostic Center has also highlighted rising PCR positivity in New York in recent years and noted that its assay detects both N. risticii and the newer species N. findlayensis, without differentiating between them. Meanwhile, a 2025 report described detection of N. risticii in fecal and fetal samples, with genomic data from an aborted equine fetus, reinforcing that abortion remains part of the clinical spectrum, even if it is less commonly emphasized than fever, diarrhea, and laminitis. (pmc.ncbi.nlm.nih.gov)

Direct expert reaction to the new systematic review was limited in publicly accessible sources, but current professional guidance is consistent with its implications. AAEP lists high fever, diarrhea that may be absent or delayed, lethargy, colic, laminitis, edema, and abortion among the possible clinical signs, and stresses that disease expression is variable. That variability, combined with a broader apparent distribution and more than one implicated Neorickettsia species, supports a more cautious diagnostic approach in compatible cases, especially during vector season or in horses with aquatic insect exposure. (aaep.org)

Why it matters: For equine veterinarians and diagnostic teams, the practical message is that Potomac horse fever may be easier to miss when it falls outside classic geographic expectations. A horse doesn’t need to be in the Potomac basin, or even necessarily in a historically emphasized U.S. hotspot, to warrant consideration. The emerging literature suggests clinicians should think in terms of ecology, seasonality, insect exposure, and compatible syndromes, rather than relying too heavily on old endemic maps. It also raises questions about whether current testing workflows should more routinely account for N. findlayensis and whether surveillance systems are capturing the full burden of disease across regions. (sciencedirect.com)

The review may also have implications for prevention conversations with pet parents. AAEP’s vaccination guidance has long noted that confirmed farm- or area-level activity can recur in future years, but vaccine performance has been an ongoing concern because field strains may differ from vaccine strains. In that context, a better understanding of where Neorickettsia species circulate, and which species are involved, could eventually shape how veterinarians discuss risk, diagnostics, and the limits of vaccination in endemic or newly recognized areas. This is an inference based on the disease ecology and guidance now available, rather than a claim made explicitly by the review itself. (aaep.org)

What to watch: The next step is likely more species-level surveillance and molecular epidemiology, especially in regions with compatible clinical cases but limited published data. Watch for follow-up work clarifying where N. risticii versus N. findlayensis are circulating, whether reported range expansion reflects true spread or better detection, and whether professional guidance on testing and prevention evolves in response. (sciencedirect.com)